How Pfizer Profited From the Pandemic
According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.” “Based on internal research, the company’s executives have frequently announced the next stage in… Read More »